Tuesday, February 9, 2010, 11:11pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Pharmaceutical Product Development Inc. (PPDI)

 At 16:00 EST: 21.03 USD  Down 1.10 (4.97%)  
MORE ON PPDI
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Pharmaceutical Product Developm (NasdaqNM:PPDI) Delayed quote dataEdit
After Hours: 21.03 0.00 (0.00%) as of 4:31pm EST on 02/09/10
Last Trade: 21.03 USD
Trade Time: 4:00PM EST
Change: Down 1.10 (4.97%)
Prev Close: 22.13
Open: 22.34
Bid: 20.80 x 200
Ask: 21.07 x 2000
1y Target Est: 51.70
Day's Range: 21.01 - 22.49
52wk Range: 17.97 - 29.36
Volume: 3,995,222
Avg Vol (3m): 1,348,400
Market Cap: 2.48B
P/E (ttm): 15.28
EPS (ttm): 1.38
Div & Yield: 0.57 (2.60%)
Pharmaceutical Product Development Inc. (PPDI)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add PPDI to Portfolio   Download Data

HEADLINES
• PPDs Global Central Lab in Singapore Earns CAP Accreditation
Business Wire (Tue 4:24pm)
• New Star Analyst Rankings for Pharmaceutical Product Developm
StarMine (Tue 9:17am)
• PPD cancellations take toll on 4Q profit
AP (Tue 8:07am)
• UPDATE - PPD Q4 profit edges past estimates
at Reuters (Mon 6:00pm)
• PHARMACEUTICAL PRODUCT DEVELOPMENT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial S
EDGAR Online (Mon 5:15pm)
• PPD Reports Fourth Quarter and Full Year 2009 Financial Results
Business Wire (Mon 5:07pm)
• BullMarket.com Updates Outlooks on CRO Stocks
PRNewswire (Mon 10:19am)
• PPD Celebrates 25 Years of Advancing Drug Development
Business Wire (Tue, Feb 2)
• The Best Undercover Dividends
at Motley Fool (Tue, Feb 2)
• PPD Announces Fourth Quarter and Full-Year 2009 Earnings Release, Webcast and Conference Call
Business Wire (Mon, Jan 25)
More Headlines for PPDI...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.8
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery and development services, post-approval expertise, and compound partnering programs.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices